公开(公告)号：US11266706B2

公开(公告)日：2022-03-08

申请号：US16760787

申请日：2018-08-09

Applicant: AMOREPACIFIC CORPORATION

Inventor： Ayoung Kim ,  Hyun Woo Jeong ,  Yong-Deog Hong ,  Jeong-Kee Kim

IPC: A61K36/82 ,  A61P1/16 ,  A61P3/04 ,  A61P3/06 ,  A61K9/00

Abstract: The present specification relates to a composition containing a tea extract with an increased specific ingredient content for prevention or alleviation of lipid metabolism disorders. The use of a preparation method and a composition according to the present specification can effectively prevent and treat lipid metabolism disorders including obesity without side effects, thereby meeting related demands and promoting the development of corresponding industries.

公开(公告)号：US10959981B2

公开(公告)日：2021-03-30

申请号：US15989544

申请日：2018-05-25

Applicant: AMOREPACIFIC CORPORATION

Inventor： Hyun Jung Shin ,  Hyun Woo Jeong ,  Ji Hae Lee ,  Dae Jin Min ,  Dae Bang Seo ,  Sang Jun Lee

IPC: A61K31/37 ,  A61K36/48

Abstract: The present invention relates to a composition for, inter alia, preventing or treating a climacteric disease, or preventing or improving a climacteric skin symptom comprising a soybean extract comprising coumestrol as an active ingredient, and more specifically relates to a composition for, inter alia, preventing or treating a climacteric disease, or preventing or improving a climacteric skin symptom comprising a germinated and fermented soybean extract comprising coumestrol as an active ingredient.

公开(公告)号：US10722442B2

公开(公告)日：2020-07-28

申请号：US16656082

申请日：2019-10-17

Applicant: AMOREPACIFIC CORPORATION

Inventor： Yong Deog Hong ,  Hyun Woo Jeong

IPC: A61K8/63 ,  A61Q19/02

Abstract: The present specification relates to a composition containing novel (20S,24R)-6-O-β-D-glucopyranosyl(1→2)-β-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, a pharmaceutically acceptable salt thereof, a hydrate or a solvate thereof as an active ingredient. The composition exhibits an excellent skin brightening effect.

公开(公告)号：US11717012B2

公开(公告)日：2023-08-08

申请号：US17217809

申请日：2021-03-30

Applicant: AMOREPACIFIC CORPORATION

Inventor： Su Hwan Kim ,  Sangyoul Na ,  Hyun Woo Jeong ,  Wanki Kim ,  Jisung Kim ,  Chan Woong Park

IPC: A23L33/105 ,  A23D9/007 ,  A23L29/269 ,  A23L33/21

CPC classification number: A23L33/105 ,  A23D9/007 ,  A23L29/272 ,  A23L33/21

Abstract: The present disclosure relates to an emulsion composition containing ginseng seed oil and ginseng berry extract, wherein the composition is a single phase. Whereas the existing composition containing a water-soluble ingredient as a main ingredient has the problem that, when ginseng seed oil is added, formulation stability is decreased as the ginseng seed oil is separated from the water-soluble ingredient, the emulsion composition according to the present disclosure exhibits superior stability because the ginseng seed oil is uniformly mixed with the water-soluble ingredient and separation of the ginseng seed oil from the water-soluble ingredient does not occur fora long period of time.

公开(公告)号：US11096921B2

公开(公告)日：2021-08-24

申请号：US15160218

申请日：2016-05-20

Applicant: AMOREPACIFIC CORPORATION

Inventor： Byung Gyu Kim ,  Hyun Woo Jeong ,  Su Kyung Kim ,  Si Young Cho ,  Chan Woong Park ,  Dae Bang Seo ,  Wan Gi Kim ,  Sang Jun Lee

IPC: A61K31/34 ,  A61K36/258 ,  A23L33/11 ,  A23L33/105 ,  A23L2/52

Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.